Effect of the Enteric Hormone Glucagon-Like Peptide (GLP-2) on the Intestinal Blood Flow in Patients With Short Bowel Syndrome
NCT00673751 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8
Last updated 2008-05-07
Summary
The aim of the study is to investigate the effect of the enteric hormone Glucagon-like Peptide (GLP-2) on patients with short bowel syndrome
Conditions
- Short Bowel Syndrome
Interventions
- DRUG
-
GLP-2
450 nmol subcutaneous
- DRUG
Sponsors & Collaborators
-
Glostrup University Hospital, Copenhagen
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- SINGLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- Denmark
Study Locations
More Related Trials
-
Effects of Gut Peptides on Bone Remodeling
NCT03574064 ·Status: COMPLETED ·Phase: NA
-
Gut Hormones and Bone Remodeling in Humans (KS-2)
NCT03573934 ·Status: COMPLETED ·Phase: NA
-
GLP-2 (Glucagonlike Peptide-2) and Blood Flow
NCT00540215 ·Status: COMPLETED ·Phase: NA
-
Glucagon-like Peptide 2 - a Glucose Dependent Glucagonotropic Hormone?
NCT03954873 ·Status: COMPLETED ·Phase: NA
-
Delineation of the Role of Glucagon-like Peptide-1 Signalling in Relation to Increased Carbohydrate Content in the Distal Small Intestines
NCT03241303 ·Status: COMPLETED ·Phase: NA
-
The Role of GIP and GLP-2 in Postprandial Splanchnic Blood Flow Distribution and Metabolism
NCT05391581 ·Status: COMPLETED ·Phase: NA
-
Investigation of GLP-2 Mechanism of Action (GA-8)
NCT03159741 ·Status: COMPLETED ·Phase: NA
-
The Effect of Exogenous Glucagon-like Peptide 2 on Cholecystokinin-induced Gallbladder Emptying
NCT04651868 ·Status: COMPLETED ·Phase: NA
-
Boosting the Secretion of GLP-2 and GLP-1 Intestinal Hormones by Nutrients
NCT01727583 ·Status: COMPLETED ·Phase: NA
-
Separate and Combined Extrapancreatic Effects of the Incretin Hormones
NCT05177653 ·Status: COMPLETED ·Phase: NA
-
Effects of Glucagon-Like Peptide-1 Analogs on Sexuality
NCT04687514 ·Status: COMPLETED ·Phase: PHASE2
-
GLP-1 Signaling in Truncally Vagotomized Subjects
NCT02940184 ·Status: UNKNOWN ·Phase: NA
-
Amylin and Glucagon-Like Peptide-1 (GLP-1): Influence on Gastric Emptying, Appetite and Food Intake in Humans
NCT00876213 ·Status: COMPLETED
-
Glucagon-like Peptide 1 (GLP-1) and Endothelial Dysfunction in Metabolic Syndrome
NCT00856700 ·Status: COMPLETED ·Phase: NA
-
GIP, GLP-1 and GLP-2 in Type 2 Diabetic Hyperglucagonemia
NCT00716170 ·Status: COMPLETED
-
The Effect of GLP-1 on the Inhibition of Glucagon Secretion
NCT01507597 ·Status: COMPLETED ·Phase: NA
-
The Role of Small Intestinal Endocrine Cells in Type 2 Diabetic Hyperglucagonemia
NCT00639613 ·Status: COMPLETED
-
Physiology of GIP(1-30)NH2 in Humans
NCT04792762 ·Status: COMPLETED ·Phase: NA
-
GIP and GLP-1 on Gastric Emptying, Appetite and Insulin-glucose
NCT01079624 ·Status: COMPLETED ·Phase: PHASE1
-
Intestinal Glucagon-like Peptide-1 (GLP-1) and the Physiological Role in Eating in Humans
NCT01900340 ·Status: COMPLETED ·Phase: PHASE1
-
Regulation of Intestinal and Hepatic Lipoprotein Production by Glucagon Like Peptide 2
NCT01958775 ·Status: COMPLETED ·Phase: PHASE3
-
The Importance of GLP-1 in Post RYGB Improvement in Glycaemic Control Type 2 Diabetic Subjects
NCT01579981 ·Status: COMPLETED ·Phase: NA
-
Effects of Oral GLP-1 on Glucose Homeostasis and Appetite Profile in Healthy Male Subjects
NCT00822003 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Effect of Liraglutide on the GIT
NCT04008290 ·Status: UNKNOWN ·Phase: PHASE4
-
Intact Vagal Innervation for and Glucagon-like Peptide-1 (GLP-1) Effects
NCT01176760 ·Status: UNKNOWN ·Phase: NA